No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Tibet Cheezheng Tibetan Medicine Co., Ltd., along with its affiliated entities, specializes in the entire lifecycle of traditional Tibetan pharmaceuticals, from their research and development to manufacturing and distribution across China. The company's diverse range of drug products addresses various medical conditions, including those impacting the cardiovascular, respiratory, digestive, nervous, and musculoskeletal systems, as well as urinary, reproductive, and gynecological health. Established in 1995, the firm is headquartered in Nyingchi, China, and operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.
www.cheezheng.com.cnNo one on the platform currently holds 002287.SZ.
No tracked institution reports a position in 002287.SZ as of their last filing.
No one on the platform has traded 002287.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002287.SZTibet Cheezheng Tibetan Medicine Co., Ltd. | $19.13 | +0.16% | $10.9B | — |
| 002030.SZDaan Gene Co., Ltd. | $5.21 | +0.00% | $7.3B | — |
| 002223.SZJiangsu Yuyue Medical Equipment & Supply Co., Ltd. | $25.84 | -0.88% | $25.9B | — |
| 002262.SZJiangsu Nhwa Pharmaceutical Co., Ltd. | $21.52 | -0.60% | $21.9B | — |
| 002294.SZShenzhen Salubris Pharmaceuticals Co., Ltd. | $29.48 | -0.41% | $32.9B | — |
| 4168.TWOGlycoNex Incorporation | $21.55 | -0.23% | $2.4B | — |
| 4174.TWOOBI Pharma, Inc. | $26.15 | +0.58% | $3.4B | — |
Source: Financial Modeling Prep · peers by sector/industry